FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management

Up | Next | Most Recent

2005N-0410: Prescription Drug User Fee Act (PDUFA): Public Meeting

Document # Received Date Filed Date Submitter Code Submitter FR Date FR Page Comment Date Files Remarks
 
NM1   10/14/2005 FDA FDA 10/18/2005 60536-60538 12/14/2005 pdf Public Meeting on 11/14/05
Signature: Jeffrey Shuren
NCR1   10/27/2005 FDA FDA 10/28/2005 62126-62126   pdf  
Signature: SHUREN, JEFFREY
EC1 11/08/2005 11/04/2005 Academia Dr. Iwan Darmansjah       htm  
Signature: Darmansjah, Iwan
EC2 11/17/2005 11/11/2005 Health Professional Ms. Marie Cowie       htm  
Signature: Cowie, Marie
EC3 11/17/2005 11/14/2005 Federal Government
U.S. House of Representatives       Attachment  
  Signature: Hinchey, Maurice
 
SUP1 11/22/2005 11/21/2005 Private Industry Hyman, Phelps & McNamara, P.C.       pdf  
Signature: Alan Kirschenbaum
LST1 12/05/2005 12/05/2005 Federal Government
Agenda for November 14, 25005 FDA and Stateholders Public Meeting
      doc, pdf  
Signature: Agenda for November 14, 25005 FDA
LST2 12/05/2005 12/05/2005 Federal Government
Biographies for November 14, 2005 Meeting       doc, pdf  
Signature: Biographies for November 14, 2005 M
TS1 12/05/2005 12/05/2005 Federal Government
Deputy Commissioner for Operations, FDA       htm, pdf, ppt Operation of the Prescription Drug User Fee Program
Signature: Janet Woodcock, MD
TS2 12/05/2005 12/05/2005 Federal Government
Director, Center for Drug Evaluation and Research, FDA
      htm, pdf, ppt  
Signature: Steven Galson MD MPH
TS3 12/05/2005 12/05/2005 Federal Government
Director, Center for Biologics Evaluation and Research, FDA
      htm, pdf, ppt  
Signature: Jesse L Goodman MD MPH
TS4 12/05/2005 12/05/2005 Academia Tufts University, Tufts Center for the Study of Drug Development
      htm, pdf, ppt Drug Development Timelines and the Prescription Drug User Fee Act
Signature: Kenneth I Kaitin, PhD
TS5 12/05/2005 12/05/2005 Academia Critical Path Institute       pdf, ppt Creating The Path for Innovative New Therapies
Signature: Raymond L Woosley MD PhD
TS6 12/05/2005 12/05/2005 Academia MIT Sloan School and National Bureau of Econimic Research
      htm, pdf, ppt PDUFA, Drug Approval Times, Drug Safety Withdrawal Rates, and the Drug Development Process: Empirical Findings
Signature: Ernst Berndt PhD
TS7 12/05/2005 12/05/2005 Academia Centers for Education & Research on Therapeutics (CERTs)
      htm, pdf, ppt AHRQ's Centers for Education & Research on Therapeutics (CERTs): A Partner for Drug Safety Surveillance
Signature: Hugh H Tilson MD DrPH
TS8 12/05/2005 12/05/2005 Consumer Group Parkinson Pipeline Project       htm, pdf, ppt A patient's perspective on user fees
Signature: Perry D Cohen PhD

Top | Up | Next | Most Recent

Page last updated December 29, 2005 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management